Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350220 · ClinicalTrials.gov registry record · Phase 2
Transfusion Strategies in Pediatric Cardiothoracic Surgery
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00350220 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 60 participants.
The verdict
NCT00350220, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best red blood cell(hemoglobin) level for infants and children following surgical repair of particular heart defects. These children often receive red blood cell transfusions after surgery, but what the best hemoglobin level is for them remains unknown.
Interventions
- OTHER transfusion strategy
- OTHER Low Hb transfusion group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350220
The ClinicalTrials.gov registry entry for NCT00350220 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transfusion strategy is the first listed.
NCT00350220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350220 about?
NCT00350220 is a clinical study titled "Transfusion Strategies in Pediatric Cardiothoracic Surgery". The purpose of this study is to determine the best red blood cell(hemoglobin) level for infants and children following surgical repair of particular heart defects. These children often receive red blood cell transfusions after surgery, but what the best hemoglobin level is for them remains unknown.
What is the current status of trial NCT00350220?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00350220?
The interventions under investigation include: transfusion strategy (OTHER), Low Hb transfusion group (OTHER).
Who is sponsoring clinical trial NCT00350220?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.